Tarja Anttila

Summary

Affiliation: University of Tampere
Country: Finland

Publications

  1. doi request reprint Clinical trials of human papillomavirus vaccines and beyond
    Matti Lehtinen
    University of Tampere, School of Health Sciences, Kalevantie 4, FI 33014 Tampere, Finland
    Nat Rev Clin Oncol 10:400-10. 2013
  2. pmc Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
    Matti Lehtinen
    School of Health Sciences, University of Tampere, Tampere 33014, Finland
    Sex Transm Infect 87:372-6. 2011
  3. ncbi request reprint Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s
    Matti Lehtinen
    National Public Health Institute, Oulu and Kuopio, Finland
    Int J Cancer 119:2612-9. 2006
  4. ncbi request reprint Associations between three types of maternal bacterial infection and risk of leukemia in the offspring
    Matti Lehtinen
    National Public Health Institute, Helsinki, Finland
    Am J Epidemiol 162:662-7. 2005
  5. ncbi request reprint Effectiveness of preventive human papillomavirus vaccination
    M Lehtinen
    National Public Health Institute and the Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki, Finland
    Int J STD AIDS 14:787-92. 2003
  6. ncbi request reprint Prospects for phase III-IV HPV vaccination trials in the Nordic countries and in Estonia
    M Lehtinen
    National Public Health Institute, Mannerheimintie 166, 00300, Helsinki, Finland
    J Clin Virol 19:113-22. 2000
  7. ncbi request reprint Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring
    Matti Lehtinen
    Department of Infectious Disease Epidemiology, National Public Health Institute, Helsinki, Finland
    Am J Epidemiol 158:207-13. 2003
  8. ncbi request reprint Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later
    Matti Lehtinen
    Department of Infectious Disease Epidemiology and Microbiology, National Public Health Institute, Helsinki, Finland
    Am J Obstet Gynecol 188:49-55. 2003
  9. ncbi request reprint Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries
    Matti Lehtinen
    School of Public Health, University of Tampere, Finland
    Am J Epidemiol 156:687-92. 2002
  10. ncbi request reprint Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction
    M Lehtinen
    National Public Health, Institute, FIN 00300, Helsinki, Finland
    J Clin Virol 22:117-24. 2001

Detail Information

Publications15

  1. doi request reprint Clinical trials of human papillomavirus vaccines and beyond
    Matti Lehtinen
    University of Tampere, School of Health Sciences, Kalevantie 4, FI 33014 Tampere, Finland
    Nat Rev Clin Oncol 10:400-10. 2013
    ..Eradication of the major oncogenic HPV types should be pursued...
  2. pmc Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
    Matti Lehtinen
    School of Health Sciences, University of Tampere, Tampere 33014, Finland
    Sex Transm Infect 87:372-6. 2011
    ..As Chlamydia trachomatis is also linked to cervical cancer, its role as a potential co-factor in the development of cervical intraepithelial neoplasia (CIN) grade 2 or higher was examined...
  3. ncbi request reprint Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s
    Matti Lehtinen
    National Public Health Institute, Oulu and Kuopio, Finland
    Int J Cancer 119:2612-9. 2006
    ..6-9.7). Similar clustering of HPV16 and HPV6/11 infections was not found. The epidemic and the clustering may be due to high transmission probability of the hrHPV types and increase in sexual activity of the index birth cohorts...
  4. ncbi request reprint Associations between three types of maternal bacterial infection and risk of leukemia in the offspring
    Matti Lehtinen
    National Public Health Institute, Helsinki, Finland
    Am J Epidemiol 162:662-7. 2005
    ..8, 95% confidence interval: 1.1, 6.9). Since H. pylori immunoglobulin G indicates chronic carriage of the microorganism, early colonization of the offspring probably differs between Iceland and Finland, two affluent countries...
  5. ncbi request reprint Effectiveness of preventive human papillomavirus vaccination
    M Lehtinen
    National Public Health Institute and the Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki, Finland
    Int J STD AIDS 14:787-92. 2003
    ....
  6. ncbi request reprint Prospects for phase III-IV HPV vaccination trials in the Nordic countries and in Estonia
    M Lehtinen
    National Public Health Institute, Mannerheimintie 166, 00300, Helsinki, Finland
    J Clin Virol 19:113-22. 2000
    ..Mass-screening programmes exist in all Nordic countries, but not in Estonia...
  7. ncbi request reprint Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring
    Matti Lehtinen
    Department of Infectious Disease Epidemiology, National Public Health Institute, Helsinki, Finland
    Am J Epidemiol 158:207-13. 2003
    ..9, 95% confidence interval: 1.5, 5.8). Results indicate that reactivation of maternal EBV infection is probably associated with childhood ALL...
  8. ncbi request reprint Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later
    Matti Lehtinen
    Department of Infectious Disease Epidemiology and Microbiology, National Public Health Institute, Helsinki, Finland
    Am J Obstet Gynecol 188:49-55. 2003
    ..Our purpose was to evaluate whether antibodies to HPV16 and HPV18 E6 and E7 proteins are useful for early diagnosis of cervical cancer by measuring the antibody response in women in whom cervical cancer later developed...
  9. ncbi request reprint Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries
    Matti Lehtinen
    School of Public Health, University of Tampere, Finland
    Am J Epidemiol 156:687-92. 2002
    ..6, 1.7) and 0.7 (95% CI: 0.3, 1.6), respectively, for HPV seropositives. In the meta-analysis, the relative risk for HSV-2 was 0.9 (95% CI: 0.6, 1.3). In both sets of data, HSV-2 did not play a role in cervical carcinogenesis...
  10. ncbi request reprint Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction
    M Lehtinen
    National Public Health, Institute, FIN 00300, Helsinki, Finland
    J Clin Virol 22:117-24. 2001
    ..PAR% has not been derived from longitudinal studies although assessment of HPV exposure prior to the neoplasia diagnosis should increase validity of such estimates...
  11. ncbi request reprint Chlamydial antibodies and risk of prostate cancer
    Tarja Anttila
    National Public Health Institute, Oulu, Finland
    Cancer Epidemiol Biomarkers Prev 14:385-9. 2005
    ..We assessed the risk of prostate cancer by exposure to Chlamydia trachomatis...
  12. ncbi request reprint Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer
    Jorma Paavonen
    Department of Obstetrics and Gynecology, University of Helsinki, Haartmaninkatu 2, 00290 Helsinki, Finland
    Am J Obstet Gynecol 189:1287-92. 2003
    ..The purpose of this study was to determine whether serum antibody response to the three versions of chlamydial heat shock protein 60 is associated with an increased risk for cervical cancer...
  13. ncbi request reprint Chlamydia pneumoniae infection and the risk of female early-onset lung cancer
    Tarja Anttila
    Int J Cancer 107:681-2. 2003
  14. ncbi request reprint A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma
    Keng Ling Wallin
    Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden
    Int J Cancer 101:371-4. 2002
    ..trachomatis in both the prediagnostic smear and in the subsequent cervical cancer. In conclusion, a prior cervical C. trachomatis infection was associated with an increased risk for development of invasive cervical cancer...
  15. ncbi request reprint Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors
    Margaret M Madeleine
    Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Int J Cancer 120:650-5. 2007
    ..0-5.1), but not for the 4 types (C, F, H, and K) that were present at very low prevalence in this population. There was an increased risk of SCC, but not AC, associated with antibodies to C. trachomatis that was not serotype specific...